Publicacións nas que colabora con José Palacios Calvo (18)

2023

  1. The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    International journal of molecular sciences, Vol. 24, Núm. 13

2022

  1. Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

    Journal of Personalized Medicine, Vol. 12, Núm. 11

2020

  1. Low prevalence of HER2-positive breast carcinomas among screening detected breast cancers

    Cancers, Vol. 12, Núm. 6, pp. 1-16

  2. The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161

2018

  1. Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2018), 20, 3, (274-285), 10.1007/s12094-017-1719-x)

    Clinical and Translational Oncology

  2. Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia

  3. Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 274-285

2016

  1. CK19 expression in breast tumours and lymph node metastasis after neoadjuvant therapy

    Histopathology, Vol. 69, Núm. 2, pp. 239-249

  2. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors

    Oncogene, Vol. 35, Núm. 21, pp. 2777-2788

  3. RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers

    European Journal of Cancer, Vol. 64, pp. 149-158

2014

  1. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer

    Endocrine-Related Cancer, Vol. 21, Núm. 4, pp. 587-599

2013

  1. Genetics of endometrial carcinoma

    Cancer Genomics: Molecular Classification, Prognosis and Response Prediction (Springer Netherlands), pp. 349-390

2012

  1. MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes

    PLoS ONE, Vol. 7, Núm. 10

2011

  1. Consenso de la Sociedad Española de Anatomía Patológica (SEAP) y de la Sociedad Española de Oncología Médica (SEOM) sobre la determinación de HER2 en el carcinoma gástrico

    Revista Espanola de Patologia, Vol. 44, Núm. 1, pp. 32-48

  2. Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 636-651

  3. Diagnosis of the sentinel lymph node in breast cancer: A reproducible molecular method: A multicentric Spanish study

    Histopathology, Vol. 58, Núm. 6, pp. 863-869

2009

  1. Guidelines for HER2 testing in breast cancer. A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia, Vol. 42, Núm. 1, pp. 3-16

  2. Guidelines for HER2 testing in breast cancer: A national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 11, Núm. 6, pp. 363-375